Fund moves

McKesson Corporation (MCK): Segall Bryant & Hamill, LLC added to its stake +10K shares

Segall Bryant & Hamill, LLC added to its stake in McKesson Corporation, per its Q4 2025 13F.

56K
Shares reported · +10K vs prior quarter
0.62%
Disclosed portfolio weight
$45.9M
Reported value
Holdings as of
Dec 31, 2025
Filed
Feb 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 18, 2024CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  2. Nov 1, 2025Federal contract · $1.4B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.41B obligated to date
  3. Nov 18, 2025CongressDisclosed purchase of MCK — reported range $1,001 - $15,000
  4. Dec 1, 2025Federal contract · $1.1B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.11B obligated to date
  5. Dec 2, 2025Congress · 1 personMembers of Congress: 2 purchases
  6. Dec 19, 2025CongressDisclosed sale of MCK — reported range $1,001 - $15,000
  7. Jan 1, 2026Federal contract · $1.1B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.09B obligated to date
  8. Jan 5, 2026InsiderOfficer sold ~$225K of MCK shares in the open market
  9. Jan 5, 2026Congress · 1 personMembers of Congress: 2 purchases
  10. Jan 16, 2026FDARecall: UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactured by Accord BioPharma, Inc., 8041 Arco Corporate Drive, Su…
  11. Feb 1, 2026Federal contract · $1.1B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.06B obligated to date
  12. Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
  13. Feb 4, 2026CongressDisclosed purchase of MCK — reported range $15,001 - $50,000
  14. Feb 6, 2026InsiderOfficer sold ~$313K of MCK shares in the open market
  15. Feb 10, 2026Layoff notice · 2700 North America Avenue West Seneca, NY, 14224Layoff notice filed in NY: 78 employees
  16. Feb 11, 2026InsiderOfficer sold ~$283K of MCK shares in the open market

What came next

  1. Feb 17, 2026InsiderOfficer sold ~$180K of MCK shares in the open market
  2. Feb 19, 2026InsiderDirector sold ~$328K of MCK shares in the open market
  3. Mar 1, 2026Federal contract · $1.2B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.18B obligated to date
  4. Mar 2, 2026InsiderOfficer sold ~$2.7M of MCK shares in the open market
  5. Mar 3, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 3, 2026, Britt J. Vitalone, the company’s Executive Vice President and Chief Financial Officer, gave notice of his intention to retire from that role. Mr. Vitalone’s last day as our CFO will be May 28, 2026, and he will remain an employee through July 1, 2026.”
  6. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  7. Apr 1, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  8. Apr 1, 2026Federal contract · $1.2B obligatedDepartment of Veterans Affairs awarded McKesson Corporation: $1.19B obligated to date
  9. Apr 8, 2026CongressDisclosed partial sale of MCK — reported range $1,001 - $15,000
  10. Apr 28, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
  11. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  12. May 7, 2026Company filing · Form 8-K · ResultsReported its results
  13. May 26, 2026Insider · 2 peopleInsiders: 2 sales (~$4.5M)
  14. Jun 1, 2026Insider · 2 peopleInsiders: 2 sales (~$1.4M)
  15. Jun 2, 2026InsiderOfficer sold ~$514K of MCK shares in the open market
  16. Jun 5, 2026InsiderOfficer sold ~$102K of MCK shares in the open market
  17. Jun 9, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  18. Jun 9, 2026InsiderCEO sold ~$3.76M of MCK shares in the open market
  19. Jun 10, 2026FDARecall: Gemcitabine Injection, 1 g per 26.3 mL (38 mg/mL), 26.3 mL Single-Dose Vial, For Intravenous Infusion ONLY, Rx only, Manufactured by: THYMOORGAN PHARMAZIE GmbH…
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for McKesson Corporation

For McKesson Corporation, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MCK page.

How this filing works

Explore the data

Common questions

What does this filing report about McKesson Corporation (MCK) stock?

Segall Bryant & Hamill, LLC added to its stake in McKesson Corporation, per its Q4 2025 13F. Now 56K shares, $45.9M reported value, 0.62% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Dec 31, 2025. Filed: Feb 13, 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about McKesson Corporation recently?

For McKesson Corporation, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the MCK page.

Does this mean MCK stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at McKesson Corporation

Everything OQRO holds on this company is on its MCK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data